Impact of a global leader on pharmaceutical practice and policy around the world

Filipa Alves da Costa; M Henman; Carmel Hughes; H Leufkens; Zaheer-Ud-Din Babar; J McElnay; M Schulz

Impact of a global leader on pharmaceutical practice and policy around the world

Filipa Alves da Costa, M Henman, Carmel Hughes, H Leufkens, Zaheer-Ud-Din Babar, J McElnay, M Schulz

Research output: Contribution to journal › Review article › peer-review

Abstract

This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and to its publication. With an interest in pharmaceutical care and in clinical pharmacy, Dr. van Mil changed practice and policy in Europe over the last decades in a very visible way, here documented through a summary of some of his main written contributions. We write this to honour his memory and contribute to the preservation of his legacy.

Original language	English
Article number	51
Number of pages	5
Journal	Journal of Pharmaceutical Policy and Practice
Volume	13
Publication status	Published - 22 Aug 2020

Access to Document

https://joppp.biomedcentral.com/track/pdf/10.1186/s40545-020-00253-zLicence: CC BY

Cite this

@article{37fb2b03ea5a46c4a25d16409824463c,

title = "Impact of a global leader on pharmaceutical practice and policy around the world",

abstract = "This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and to its publication. With an interest in pharmaceutical care and in clinical pharmacy, Dr. van Mil changed practice and policy in Europe over the last decades in a very visible way, here documented through a summary of some of his main written contributions. We write this to honour his memory and contribute to the preservation of his legacy.",

keywords = "Pharmaceutical care, Medication review, Clinical pharmacy, Europe",

author = "{Alves da Costa}, Filipa and M Henman and Carmel Hughes and H Leufkens and Zaheer-Ud-Din Babar and J McElnay and M Schulz",

year = "2020",

month = aug,

day = "22",

language = "English",

volume = "13",

journal = "Journal of Pharmaceutical Policy and Practice",

issn = "2052-3211",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Impact of a global leader on pharmaceutical practice and policy around the world

AU - Alves da Costa, Filipa

AU - Henman, M

AU - Hughes, Carmel

AU - Leufkens, H

AU - Babar, Zaheer-Ud-Din

AU - McElnay, J

AU - Schulz, M

PY - 2020/8/22

Y1 - 2020/8/22

N2 - This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and to its publication. With an interest in pharmaceutical care and in clinical pharmacy, Dr. van Mil changed practice and policy in Europe over the last decades in a very visible way, here documented through a summary of some of his main written contributions. We write this to honour his memory and contribute to the preservation of his legacy.

AB - This commentary describes the contributions of a Dutch pharmacist who contributed in a unique manner to the development of community pharmacy practice in Europe, to the evolution of practice-based research and to its publication. With an interest in pharmaceutical care and in clinical pharmacy, Dr. van Mil changed practice and policy in Europe over the last decades in a very visible way, here documented through a summary of some of his main written contributions. We write this to honour his memory and contribute to the preservation of his legacy.

KW - Pharmaceutical care

KW - Medication review

KW - Clinical pharmacy

KW - Europe

M3 - Review article

VL - 13

JO - Journal of Pharmaceutical Policy and Practice

JF - Journal of Pharmaceutical Policy and Practice

SN - 2052-3211

M1 - 51

ER -

Impact of a global leader on pharmaceutical practice and policy around the world

Abstract

Access to Document

Fingerprint

Cite this